Go to the list of all blogs
Jimmy Landsman's Avatar
published in Blogs
Nov 18, 2026
TickeronGET DAILY SIGNALS
BMAR: Exploring the Innovator U.S. Equity Buffer ETF – March

BMAR: Exploring the Innovator U.S. Equity Buffer ETF – March

Key Takeaways

  • BMAR is the Innovator U.S. Equity Buffer ETF – March, an actively managed "defined outcome" exchange-traded fund (ETF) launched by Innovator ETFs in 2020.
  • The fund seeks to track the price return of the SPDR S&P 500 ETF Trust (SPY) up to a preset cap, while buffering investors against the first 9% of losses over each one-year outcome period.
  • BMAR is built primarily from FLEX Options (customizable exchange-traded options) rather than direct stock holdings, giving it a very small number of portfolio positions.
  • The fund carries a net expense ratio of 0.79% and is classified as non-diversified.
  • BMAR is designed for investors seeking broad U.S. large-cap exposure with a defined degree of downside protection, at the cost of capped upside.

What BMAR Aims to Deliver

BMAR represents a specialized type of ETF focused on defined outcome or buffer strategies. Issued by Innovator ETFs, the fund is the March series within their U.S. Equity Buffer lineup, with each series resetting on its own monthly schedule. Its core approach is straightforward: capture a substantial portion of the S&P 500's gains up to a set limit while absorbing the initial segment of any downturn. This positions BMAR as a potential option for investors looking to maintain equity exposure with a layer of structured downside support.

Inside the Fund's Mechanics

The investment objective centers on matching the price return of the SPDR S&P 500 ETF Trust (SPY) up to a predetermined cap, while providing a buffer against the first 9% of losses during each roughly one-year outcome period. After each period ends, the cap and buffer are reset. Rather than holding individual stocks directly, BMAR allocates at least 80% of its assets to FLEX Options on SPY, with the balance typically in cash or equivalents. This results in a compact portfolio, usually under ten holdings dominated by options and short-term instruments. Sector exposure effectively aligns with the S&P 500, historically weighted toward technology, financials, communication services, healthcare, and consumer discretionary. Key details include an issuer of Innovator Capital Management, a 2020 launch, trading on Cboe BZX, a 0.79% net expense ratio, annual rebalancing, and non-diversified status. I also checked this using Tickeron’s AI Screener to see how the structure compares with similar products.

The Appeal for Investors

BMAR draws interest from those seeking equity market participation without full exposure to sharp declines. The 9% buffer is structured to absorb the initial losses in the referenced index over a complete outcome period. It delivers broad large-cap U.S. exposure without the need to pick individual stocks, potentially serving as a steadier building block in a portfolio. The clear trade-off remains the upside cap, which can cause the fund to lag a standard index fund during strong rallies.

Potential Drawbacks to Consider

Investors should note that the cap and buffer apply fully only to those holding through an entire outcome period; mid-period purchases or sales can produce different results. The non-diversified nature and heavy use of derivatives bring considerations around counterparty risk and liquidity for FLEX Options. The 0.79% expense ratio exceeds that of many plain index ETFs. In addition, the buffer does not eliminate market risk beyond 9%, and the fund tracks SPY's price return, excluding dividends, which may affect total returns over time relative to dividend-inclusive benchmarks.

Enhancing Research with Tickeron Tools

In my analysis of buffer ETFs like BMAR, I frequently rely on Tickeron's AI Screener to apply technical indicators, fundamentals, and custom filters across thousands of securities. This helps surface ideas that align with specific strategies and build targeted watchlists efficiently. The platform's AI-generated signals add another layer when evaluating defined-outcome products.

Conclusion

BMAR packages S&P 500 exposure within an options-based structure that caps gains while cushioning the first 9% of losses annually. This approach highlights the expanding defined outcome ETF space and offers a distinct way to manage downside without fully stepping away from equities. Suitability hinges on individual goals, time frame, and comfort with capped returns, all of which merit careful evaluation.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: BMAR

Contributor

My name is Jimmy, and I’m a financial analyst focused on identifying compelling opportunities across the ETF market. Each day, I analyze hundreds of ETFs to uncover potential trading and investment opportunities using a broad range of market factors. For short-term trading, I rely heavily on technical analysis, including price channels, momentum indicators, support and resistance levels, trend patterns, and other market signals. At the same time, I dedicate significant attention to evaluating ETFs from a long-term investment perspective. My objective is to build a well-balanced ETF portfolio that combines core investment holdings with more tactical and speculative positions. The goal is to create a portfolio that can participate effectively in market rallies while also remaining resilient during periods of volatility and market corrections.


BMAR's Indicator enters downward trend

The Aroon Indicator for BMAR entered a downward trend on November 18, 2026. Tickeron's A.I.dvisor identified a pattern where the AroonDown red line was above 70 while the AroonUp green line was below 30 for three straight days. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options. A.I.dvisor looked at 80 similar instances where the Aroon Indicator formed such a pattern. In 62 of the 80 cases the stock moved lower. This puts the odds of a downward move at 77%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

The 10-day RSI Indicator for BMAR moved out of overbought territory on October 14, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 58 similar instances where the indicator moved out of overbought territory. In 33 of the 58 cases, the stock moved lower in the following days. This puts the odds of a move lower at 57%.

The Momentum Indicator moved below the 0 level on November 16, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on BMAR as a result. In 44 of 77 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 57%.

The Moving Average Convergence Divergence Histogram (MACD) for BMAR turned negative on October 15, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 49 similar instances when the indicator turned negative. In 24 of the 49 cases the stock turned lower in the days that followed. This puts the odds of success at 49%.

BMAR moved below its 50-day moving average on November 12, 2026 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for BMAR crossed bearishly below the 50-day moving average on November 05, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 7 of 11 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 64%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where BMAR declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 54%.

Bullish Trend Analysis

The Stochastic Oscillator demonstrated that the ticker has stayed in the oversold zone for 1 day, which means it's wise to expect a price bounce in the near future.

Following a +1.93% 3-day Advance, the price is estimated to grow further. Considering data from situations where BMAR advanced for three days, in 287 of 378 cases, the price rose further within the following month. The odds of a continued upward trend are 76%.

BMAR may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Industry description

The investment seeks to provide investors with returns that match the price return of the SPDR® S&P 500® ETF Trust. The fund invests at least 80% of its net assets in FLexible EXchange® Options (“FLEX Options”) that reference the SPDR® S&P 500® ETF Trust (the “underlying ETF”). FLEX Options are exchange-traded options contracts with uniquely customizable terms. Although guaranteed for settlement by the Options Clearing Corporation (the "OCC"), FLEX Options are still subject to counterparty risk with the OCC and may be less liquid than more traditional exchange-traded options. It is non-diversified.
AI Robots 7
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
Interact to see
Advertisement
UNH dropped -7.80% to $359.29 from Tuesday's $389.68 close, extending a two-session decline to roughly -13% and touching its lowest level in about seven weeks; the move occurred during regular market hours. The selloff accelerated on the CMS "CRUSH" proposal unveiled Nov. 16, which would extrapolate Medicare Advantage risk-adjustment audit findings from samples across entire contracts back to payment year 2018 and drop the fee-for-service adjuster; CMS estimates roughly $9 billion in industry clawbacks per payment year, and UnitedHealth, the largest MA insurer, has not sized its exposure.
SAP's U.S. shares fell from Monday's close of $233.83 to $221.99 by late Tuesday morning in New York, a -5.06% decline recorded during regular trading hours. The company-specific trigger was the announced exit of Chief Customer Officer Thomas Saueressig, an executive board member since 2019, who will leave at the end of March 2027 to become CEO of IONOS; the disclosure came before the U.S. open.
Different growth engines: MRVL is riding accelerating AI data-center demand for custom chips and networking, while QCOM remains heavily tied to a soft smartphone market. Momentum contrast: Marvell's data-center revenue guidance has strengthened, whereas Qualcomm's near-term outlook has been pressured by memory-supply constraints and shrinking handset volumes.
TMC fell from Monday's $2.11 close to $1.96 by 10:10 a.m. ET, a -7.11% decline that occurred entirely in the regular session after an early premarket gain faded. No verified news or fundamental catalyst found for the drop; the move is likely technical, extending the post-Q3 unwind that followed NOAA pushing its certification decision to mid-December, with the stock averaging a 4.0% daily swing and logging 11 sessions of 7%-or-larger moves in the last 60.
IonQ slid from Monday's close of $26.45 to $24.73 on Tuesday, a -6.50% move that unfolded during regular trading hours after modest premarket gains faded. The decline was sector-driven rather than company-specific: quantum and AI-adjacent speculative names extended a multi-session liquidation ahead of Nvidia's quarterly report, with unease over Nvidia's abrupt CEO transition keeping risk appetite weak.